High on-treatment platelet reactivity: risk factors and 5-year outcomes in patients with acute myocardial infarction
Author:
Open Access
- 1 January 2016
- journal article
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 17 (2) , 113-118
Abstract
The aim of the present study was to assess long-term prognostic value of high on-treatment platelet reactivity (HTPR) in patients after acute myocardial infarction (MI) and its association with possible risk factors. This prospective, case-control study was an observation of 198 patients who had acute MI. Response to aspirin and clopidogrel was assessed using impedance aggregometry. Patients were divided into groups of adequate response, dual poor responsiveness (DPR), poor responsiveness to aspirin (PRA), and poor responsiveness to clopidogrel (PRC). Simultaneously, potential risk factors of HTPR development were recorded. After 5 years, MI recurrence and overall mortality were assessed. HTPR was more frequent in New York Heart Association Class III and IV patients, and in patients with left ventricle systolic dysfunction. Five-year mortality rate was higher in all groups of patients with HTPR compared to patients with sufficient response to antiplatelet treatment: in PRA patients, 38.1% vs. 19.2%, p<0.01; in PRC patients, 45.2% vs. 17.3%, p<0.001; and in DPR patients, 50.0% vs. 19.9%, p<0.05. Risk of repeat MI also increased (hazard ratio [HR] 4.0, p<0.05 for DPR group; HR 4.37, p<0.01 for PRA group; and HR 3.25, p<0.05 for PRC group). PRA, PRC, and DPR are independent predictors of increased 5-year mortality and risk of repeat non-fatal MI. The study has demonstrated that HTPR is frequently observed in patients with severe heart failure and left ventricle systolic dysfunction.Keywords
This publication has 34 references indexed in Scilit:
- P2RY12 gene polymorphisms and effect of clopidogrel on platelet aggregation.2013
- Multiple electrode aggregometry: a new device to measure platelet aggregation in whole blood.2006
- Platelets and heart failureEuropean Heart Journal, 2006
- Platelet Response to Low-Dose Enteric-Coated Aspirin in Patients With Stable Cardiovascular DiseaseJACC, 2005
- Aspirin resistance and a single geneThe American Journal of Cardiology, 2005
- A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular diseaseJACC, 2003
- Atorvastatin Reduces the Ability of Clopidogrel to Inhibit Platelet AggregationCirculation, 2003
- Increased Platelet-Collagen Interaction Associated With Double Homozygosity for Receptor Polymorphisms of Platelet GPIa and GPIIIaArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Aspirin resistance in cardiovascular disease: a review of prevalence, mechanisms, and clinical significance.2002
- Evaluation of Sample Size and Power for Analyses of Survival with Allowance for Nonuniform Patient Entry, Losses to Follow-Up, Noncompliance, and StratificationBiometrics, 1986